Data cohorts in the neuGRID2 environment
To serve scientific research communities neuGRID2 is offering different datasets with different access rights.
NeuGRID offers two main access rights:
- OPEN ACCESS: downloading and analyzing these data from neuGRID2 is free – as soon as user fill the on-line form no other restriction or formalities are needed.
- RESTRICTED ACCESS: access is restricted exclusively to co-workers or collaborators of the Consortium. Authorization from external users to access these data must be obtained from the owner Consortium, such as PharmaCOG, by submitting a scientific abstract via the on-line form and eventually signing an ad-hoc scientific agreement.
OASIS
I-ADNI
|
![]() |
|
OPEN-ACCESS |
|
I-ADNI is a cross sectional study and consists of 262 patients with subjective memory impairment, mild cognitive impairment, Alzheimer’s dementia and frontotemporal dementia enrolled in 7 Italian centers. Few cognitively healthy elderly controls were also included. This study has provided standardization of MRI acquisition and imaging marker collection across different Italian clinical units and equipment. This is a mandatory step to the implementation of imaging biomarkers in clinical routine for early and differential diagnosis. MRI site qualification and MP-RAGE quality assessment was applied following the ADNI-1 procedures. |
PHARMACOG – MCI Patients
PHARMACOG – DTI – Reproducibility
PHARMACOG – Morphometry – Reproducibility
PHARMACOG – resting – state – fMRI – Reproducibility
ARWIBO
EDSD
|
![]() |
|
OPEN-ACCESS |
|
The EDSD data include 471 Diffusion Tensor Imaging (DTI) and 471 structural MRI scans (MPRAGE) from patients with Alzheimer’s Disease (AD), Mild Cognitive Impairment (MCI) and Healthy Elderly subjects. EDSD is a cross-sectional multicenter study. |
VITA
|
![]() |
|
OPEN-ACCESS |
|
VITA is a population based cohort-study of all 75-years old inhabitant of a geographically defined area of Vienna. VITA is composed by 606 subjects followed longitudinally for 4 years. Recruitment took place between May 200 and October 2002. The primary focus of the VITA work group was to establish a prospective age cohort for evaluation of prognostic criteria for the development of AD. |
WMH-AD
|
![]() |
|
OPEN-ACCESS |
|
WMH-AD is interested in white matter hyperintensities (WMH) and at least 50% of patients with AD have been documented with this pathological change. White mater provides anatomic connections among brain regions and severe WMHs burden may contribute to cognitive impairment. WMH-AD is composed by 92 subjects (30 men and 62 women) followed cross-sectionally. The patients underwent to the following imaging scans: T13D, FLAIR and DTI (61 gradient directions) at 3.0 Tesla. |